India’s Top Court To Consider Recommendations On Clinical Trials Regulation In December
This article was originally published in PharmAsia News
Executive Summary
In the latest judicial drama in India, the Supreme Court will wait until Oct. 21 before deciding whether to allow 162 approved clinical trials to move forward. The court will also consider by December how the law should be applied to clinical trials, including recommendations for an overhaul.